Largest pharmaceutical companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by cash on hand, at AED 72.4B, ahead of Merck & Co (AED 53.5B) and Novartis (AED 42B). Figures as of 18 Nov 2026, 20:48 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonAED 72.4B
- Median
- AED 2.1B
- Combined market value
- AED 18.62T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | AED 72.4B | AED 2.42T | AED 1,005.13 | 1.81% down | 38% up | ||
| 2 | Merck & CoMRK · Health Care | AED 53.5B | AED 1.25T | AED 507.23 | 3.68% down | 51% up | ||
| 3 | NovartisNVS · Health Care | AED 42B | AED 1.08T | AED 570.35 | 2.42% down | 25% up | ||
| 4 | Bristol-Myers SquibbBMY · Health Care | AED 37.5B | AED 448.3B | AED 219.31 | 2.67% down | 34% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | AED 31.3B | AED 666.5B | AED 384.81 | 0.06% up | 17% down | ||
| 6 | SanofiSNY · Health Care | AED 31.2B | AED 416.1B | AED 173.27 | 0.75% down | 4% down | ||
| 7 | Eli LillyLLY · Health Care | AED 26.7B | AED 4.54T | AED 5,092.29 | 2.06% down | 35% up | ||
| 8 | AstraZenecaAZN · Health Care | AED 21B | AED 1.02T | AED 657.27 | 1.82% down | 2% up | ||
| 9 | AbbVieABBV · Health Care | AED 19.2B | AED 1.86T | AED 1,051.70 | 2.21% down | 26% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | AED 18.7B | AED 501.6B | AED 1,978.22 | 0.82% up | 27% up | ||
| 11 | BeOne MedicinesONC · Health Care | AED 16.7B | AED 169.4B | AED 1,483.11 | 2.29% down | 17% up | ||
| 12 | GSKGSK · Health Care | AED 16.6B | AED 358.2B | AED 178.72 | 1.18% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | AED 14.4B | AED 639.3B | AED 145.04 | 2.97% down | 17% down | ||
| 14 | Takeda PharmaceuticalTAK · Health Care | AED 13.7B | AED 249.4B | AED 78.05 | 1.80% down | 54% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | AED 13.1B | AED 180.6B | AED 154.81 | 1.10% down | 74% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | AED 11.5B | AED 359.2B | AED 3,472.36 | 1.29% down | 36% up | ||
| 17 | ZoetisZTS · Health Care | AED 8.5B | AED 127.8B | AED 314.44 | 2.55% up | 29% down | ||
| 18 | GenmabGMAB · Health Care | AED 6.3B | AED 115.9B | AED 187.98 | 1.50% down | 70% up | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | AED 6.1B | AED 73.5B | AED 548.91 | 4.50% down | 66% down | ||
| 20 | United TherapeuticsUTHR · Health Care | AED 5.7B | AED 90.7B | AED 2,130.10 | 0.71% down | 23% up | ||
| 21 | Roivant SciencesROIV · Health Care | AED 5.2B | AED 102.9B | AED 142.07 | 0.08% down | 90% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | AED 5.1B | AED 58.1B | AED 905.31 | 2.40% up | 37% up | ||
| 23 | ViatrisVTRS · Health Care | AED 4.9B | AED 85.6B | AED 74.71 | 0.54% down | 96% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | AED 4.8B | AED 43.8B | AED 225.90 | 5.12% up | 11% up | ||
| 25 | PfizerPFE · Health Care | AED 4.2B | AED 587.4B | AED 103.06 | 1.44% down | 14% up | ||
| 26 | PTC TherapeuticsPTCT · Health Care | AED 3.6B | AED 18.4B | AED 220.59 | 0.50% down | 20% down | ||
| 27 | GrifolsGRFS · Health Care | AED 3.4B | AED 21.2B | AED 31.09 | 1.91% down | 1% up | ||
| 28 | Legend BiotechLEGN · Health Care | AED 3.3B | AED 11.7B | AED 60.09 | 1.55% up | 42% down | ||
| 29 | Ascendis PharmaASND · Health Care | AED 2.5B | AED 65.1B | AED 992.53 | 0.35% down | 28% up | ||
| 30 | Royalty PharmaRPRX · Health Care | AED 2.3B | AED 145.1B | AED 252.40 | 0.06% up | 78% up | ||
| 31 | ABIVAXABVX · Health Care | AED 2.1B | AED 26.9B | AED 306.83 | 1.75% up | 27% down | ||
| 32 | BridgeBio PharmaBBIO · Health Care | AED 2.1B | AED 55.6B | AED 285.37 | 1.17% up | 17% up | ||
| 33 | Elanco Animal HealthELAN · Health Care | AED 2B | AED 49.1B | AED 98.32 | 3.56% up | 20% up | ||
| 34 | InsmedINSM · Health Care | AED 1.9B | AED 96.7B | AED 440.64 | 1.55% down | 40% down | ||
| 35 | AlkermesALKS · Health Care | AED 1.4B | AED 28.8B | AED 171.49 | 2.73% up | 58% up | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | AED 1.4B | AED 16.9B | AED 101.59 | 2.60% up | 64% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | AED 1.3B | AED 31.5B | AED 1,127.43 | 0.62% up | 61% up | ||
| 38 | Belite BioBLTE · Health Care | AED 1.3B | AED 23.5B | AED 577.51 | 0.31% down | 31% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | AED 1.2B | AED 25.9B | AED 492.39 | 1.39% down | 7% down | ||
| 40 | Cogent BiosciencesCOGT · Health Care | AED 1.1B | AED 17.8B | AED 102.51 | 0.22% up | 20% down | ||
| 41 | Mirum PharmaceuticalsMIRM · Health Care | AED 1.1B | AED 22.1B | AED 338.75 | 0.30% up | 31% up | ||
| 42 | Amneal PharmaceuticalsAMRX · Health Care | AED 1B | AED 27.9B | AED 80.07 | 3.22% up | 83% up | ||
| 43 | Definium TherapeuticsDFTX · Health Care | AED 947M | AED 14.7B | AED 107.05 | 0.80% down | 169% up | ||
| 44 | Arrowhead PharmaceuticalsARWR · Health Care | AED 832.1M | AED 22.4B | AED 158.80 | 0.57% up | 10% up | ||
| 45 | Summit TherapeuticsSMMT · Health Care | AED 827.4M | AED 30.9B | AED 38.68 | 1.31% down | 36% down | ||
| 46 | Madrigal PharmaceuticalsMDGL · Health Care | AED 729.8M | AED 33.9B | AED 1,460.95 | 5.74% down | 24% down | ||
| 47 | Ligand PharmaceuticalsLGND · Health Care | AED 642.5M | AED 21.9B | AED 1,093.75 | 1.35% up | 43% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | AED 608.2M | AED 27.4B | AED 348.59 | 0.21% down | 126% up | ||
| 49 | Dr. Reddy's LaboratoriesRDY · Health Care | AED 600.6M | AED 45.8B | AED 54.98 | 1.22% up | 5% up | ||
| 50 | Protagonist TherapeuticsPTGX · Health Care | AED 471.6M | AED 30.4B | AED 465.63 | 1.69% up | 46% up | ||
| 51 | CytokineticsCYTK · Health Care | AED 450M | AED 26.3B | AED 188.93 | 0.41% down | 20% down | ||
| 52 | Corcept TherapeuticsCORT · Health Care | AED 442.6M | AED 27.2B | AED 248.80 | 3.33% down | 8% down | ||
| 53 | Travere TherapeuticsTVTX · Health Care | AED 341.7M | AED 17.7B | AED 183.98 | 1.98% down | 44% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | AED 314.8M | AED 35.4B | AED 373.13 | 8.29% up | 286% up | ||
| 55 | TG TherapeuticsTGTX · Health Care | AED 290.7M | AED 36.8B | AED 243.26 | 5.61% up | 107% up | ||
| 56 | ErascaERAS · Health Care | AED 271.1M | AED 17.6B | AED 50.15 | 1.69% down | 403% up | ||
| 57 | Edgewise TherapeuticsEWTX · Health Care | AED 224.6M | AED 16.7B | AED 152.46 | 1.26% down | 88% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | AED 199.4M | AED 30.3B | AED 437.30 | 2.10% up | 13% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | AED 187.6M | AED 17.5B | AED 310.05 | 2.95% down | 113% up | ||
| 60 | Oruka TherapeuticsORKA · Health Care | AED 172.4M | AED 23.8B | AED 351.17 | 0.74% down | 241% up | ||
| 61 | VeradermicsMANE · Health Care | AED 79.9M | AED 19.3B | AED 456.80 | 1.01% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6729 AED).
Questions and answers
Which pharmaceutical companies rank first by cash on hand?
Johnson & Johnson (AED 72.4B), Merck & Co (AED 53.5B) and Novartis (AED 42B) are the top three of the 61 pharmaceutical companies ranked by cash on hand as of 18 Nov 2026, 20:48 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by cash on hand.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by cash on hand have a combined market value of AED 18.62T as of 18 Nov 2026, 20:48 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.